Clinical Trial Detail

NCT ID NCT03361800
Title Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

triple-receptor negative breast cancer

estrogen-receptor positive breast cancer

Therapies

Entinostat

Age Groups: adult senior

No variant requirements are available.